Predictors of Adherence to Statins for Primary Prevention
- 876 Downloads
Statins are potent drugs for reducing cholesterol and cardiovascular disease; however, their effectiveness is significantly compromised by poor adherence. This prospective study was designed to identify potentially modifiable patient factors including medication, disease, and diet beliefs related to statin adherence.
Veterans (n = 71) given their first prescription of a statin for primary prevention were interviewed at baseline, 3 months, and 6 months regarding medication, disease, and diet beliefs along with self-reported statin adherence.
At 6-month follow-up, 55% of the cohort was non-adherent with 10% reporting never having started their statin, 50% reporting misconceptions about the duration of treatment and a median use of <2 months among those who discontinued their statin. Multivariate predictors of non-adherence were expected short treatment duration (OR = 3.6, 1.4–9.4), low perceived risk of myocardial infarction (OR = 3.1, 1.1–8.7), concern about potential harm from statins (OR = 2.5, 1.0–6.3), being Hispanic (OR = 3.9, 1.0–15.2), and younger age (OR = 4.2, 1.1–15.8).
Poor adherence to statins was common in this primary prevention population with frequent early discontinuation despite access to low-cost medicines. Patient factors regarding the perception of risk, toxic effects of medication, expected treatment duration, as well as socio-demographic factors, were significant predictors of poor adherence and warrant further exploration.
Key wordsadherence cardiovascular disease statins primary prevention predictor health beliefs
- 1.Writing Group M, Rosamond W, Flegal K, et al. Heart disease and stroke statistics—2007 update. A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2006;106:1799–818.Google Scholar
- 2.Third Report of the National Cholesterol Education Program (NCEP). Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143.Google Scholar
- 10.Morisky D, Ward H, Liu K. Self-reported medication taking behavior: a valid indicator for assessing compliance (abstract 26352). In: 129th meeting of the American Pharmacy Association. Atlanta; 2001.Google Scholar
- 13.Leventhal H, Diefenbach M, Leventhal E. Illness cognition: Using common sense to understand treatment adherence and affect cognition interactions. Cogn Ther Res 1992;16.Google Scholar
- 21.Benner JS, Tierce JC, Ballantyne CM, et al. Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy. Pharmacoecon 2004;22:13–33.Google Scholar